Composition for the treatment of inflammatory conditions
US7772213B2 · kind B2 · utility
0Cited by
7References
17Claims
0Family size
Inventor
Key dates
| Filing date | Jul 27, 2006 |
| Grant date | Aug 10, 2010 |
| Priority date | — |
| Expiry date | Nov 12, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/717
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel treatment for topical inflammatory conditions such as acne, eczema, shingles, insect bites and hives is provided, consisting of the application of a pharmaceutical cream or ointment which incorporates hydroxypropyl methylcellulose acetate succinate (“HPMCAS”) in a micronized form and which preferably contains one or more thickeners, a bio-adhesive agent and water so that the formulation, when applied, can stick to the area to be treated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.